Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKiris, Irem
dc.contributor.authorBasar, Merve Karayel
dc.contributor.authorSahin, Betul
dc.contributor.authorGurel, Busra
dc.contributor.authorCoskun, Julide
dc.contributor.authorMroczek, Tomasz
dc.contributor.authorBaykal, Ahmet Tarik
dc.date.accessioned2025-10-16T15:20:05Z
dc.date.issued2021
dc.identifier.doi10.2174/0929867327999201116193126
dc.identifier.otherWOS:000672743900008
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7460
dc.publisherBENTHAM SCIENCE PUBL LTD
dc.sourceCURRENT MEDICINAL CHEMISTRY
dc.subjectAlzheimer's Disease
dc.subject5xFAD
dc.subjectLycoramine
dc.subjectGalantamine
dc.subjectLabel\\-free Proteomics
dc.subjectNeurodegeneration
dc.titleEvaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS